| Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind … GL Chupp, ES Bradford, FC Albers, DJ Bratton, J Wang-Jairaj, LM Nelsen, ... The Lancet Respiratory Medicine 5 (5), 390-400, 2017 | 551 | 2017 |
| CPAP vs mandibular advancement devices and blood pressure in patients with obstructive sleep apnea: a systematic review and meta-analysis DJ Bratton, T Gaisl, AM Wons, M Kohler Jama 314 (21), 2280-2293, 2015 | 344 | 2015 |
| Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised … SE Craig, M Kohler, D Nicoll, DJ Bratton, A Nunn, R Davies, J Stradling Thorax 67 (12), 1090-1096, 2012 | 241 | 2012 |
| Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): a 12-month, multicentre, randomised trial A McMillan, DJ Bratton, R Faria, M Laskawiec-Szkonter, S Griffin, ... The Lancet Respiratory Medicine 2 (10), 804-812, 2014 | 223 | 2014 |
| Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled … DJ Bratton, JR Stradling, F Barbé, M Kohler Thorax 69 (12), 1128-1135, 2014 | 196 | 2014 |
| Anti–IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison W Busse, G Chupp, H Nagase, FC Albers, S Doyle, Q Shen, DJ Bratton, ... Journal of Allergy and Clinical Immunology 143 (1), 190-200. e20, 2019 | 195 | 2019 |
| Effects of CPAP and mandibular advancement devices on health-related quality of life in OSA: a systematic review and meta-analysis E Kuhn, EI Schwarz, DJ Bratton, VA Rossi, M Kohler Chest 151 (4), 786-794, 2017 | 128 | 2017 |
| Comparison of the effects of continuous positive airway pressure and mandibular advancement devices on sleepiness in patients with obstructive sleep apnoea: a network meta-analysis DJ Bratton, T Gaisl, C Schlatzer, M Kohler The Lancet Respiratory Medicine 3 (11), 869-878, 2015 | 120 | 2015 |
| CPAP improves endothelial function in patients with minimally symptomatic OSA: results from a subset study of the MOSAIC trial M Kohler, S Craig, JCT Pepperell, D Nicoll, DJ Bratton, AJ Nunn, ... Chest 144 (3), 896-902, 2013 | 100 | 2013 |
| Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials BC Kahan, S Cro, CJ Doré, DJ Bratton, S Rehal, NA Maskell, N Rahman, ... Trials 15, 1-6, 2014 | 99 | 2014 |
| The impact of obstructive sleep apnoea on the aorta T Gaisl, DJ Bratton, M Kohler European Respiratory Journal 46 (2), 532-544, 2015 | 73 | 2015 |
| A multicentre randomised controlled trial and economic evaluation of continuous positive airway pressure for the treatment of obstructive sleep apnoea syndrome in older people … A McMillan, DJ Bratton, R Faria, M Laskawiec-Szkonter, S Griffin, ... Health Technology Assessment (Winchester, England) 19 (40), 1, 2015 | 67 | 2015 |
| Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthma FC Albers, C Licskai, P Chanez, DJ Bratton, ES Bradford, SW Yancey, ... Respiratory medicine 159, 105806, 2019 | 62 | 2019 |
| Premenopausal endogenous oestrogen levels and breast cancer risk: a meta-analysis K Walker, DJ Bratton, C Frost British journal of cancer 105 (9), 1451-1457, 2011 | 57 | 2011 |
| A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis DJ Bratton, PPJ Phillips, MKB Parmar BMC medical research methodology 13, 1-14, 2013 | 51 | 2013 |
| Severe eosinophilic asthma with nasal polyposis: a phenotype for improved sinonasal and asthma outcomes with mepolizumab therapy P Howarth, G Chupp, LM Nelsen, ES Bradford, DJ Bratton, SG Smith, ... Journal of Allergy and Clinical Immunology 145 (6), 1713-1715, 2020 | 50 | 2020 |
| Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA JR Stradling, SE Craig, M Kohler, D Nicoll, L Ayers, AJ Nunn, DJ Bratton Thorax 70 (2), 181-182, 2015 | 48 | 2015 |
| Obstructive sleep apnoea and quality of life in Ehlers-Danlos syndrome: a parallel cohort study T Gaisl, C Giunta, DJ Bratton, K Sutherland, C Schlatzer, N Sievi, ... Thorax 72 (8), 729-735, 2017 | 47 | 2017 |
| Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA FC Albers, A Papi, C Taillé, DJ Bratton, ES Bradford, SW Yancey, N Kwon Respiratory research 20 (1), 1-10, 2019 | 40 | 2019 |
| Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility M Humbert, FC Albers, DJ Bratton, SW Yancey, MC Liu, S Hozawa, ... Respiratory Medicine 154, 69-75, 2019 | 39 | 2019 |
Thomas Gaisl MD MPH PhDHarvard University & University of ZurichVerified email at hsph.harvard.edu
